GC
KNSA icon

Globeflex Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Globeflex Capital’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.5M Hold
93,396
– – 0.68% 45
2025
Q4 		$3.85M Hold
93,396
– – 0.59% 59
2025
Q3 		$3.63M Buy
93,396
+4,800
+5% +$156K 0.56% 58
2025
Q2 		$2.45M Hold
88,596
– – 0.2% 110
2025
Q1 		$1.97M Hold
88,596
– – 0.18% 112
2024
Q4 		$1.75M Buy
88,596
+60,656
+217% +$1.38M 0.15% 126
2024
Q3 		$698K Buy
27,940
+21,150
+311% +$515K 0.07% 233
2024
Q2 		$127K Buy
+6,790
New +$127K 0.01% 345
2023
Q4 		– Sell
-9,338
Closed -$162K – 494
2023
Q3 		$162K Buy
+9,338
New +$157K 0.02% 338

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Globeflex Capital's KNSA Position: Q1 2026 in Review

Globeflex Capital held its Kiniksa Pharmaceuticals (KNSA) position steady in Q1 2026 at 93,396 shares worth $4.5M. The position accounts for 0.68% of the portfolio, ranked #45.

Globeflex Capital first reported a position in KNSA in Q3 2023 and has held it in 9 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Globeflex Capital held 93,396 shares of Kiniksa Pharmaceuticals worth $4.5M as of Q1 2026.
  • Globeflex Capital left its Kiniksa Pharmaceuticals share count unchanged in Q1 2026.
  • Kiniksa Pharmaceuticals made up 0.68% of Globeflex Capital's portfolio in Q1 2026, its #45 holding.
  • Globeflex Capital first reported a position in Kiniksa Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.